M RP6 (ABCC6) is a member of the subfamily of the multidrug resistance proteins (MRPs, reviewed by Borst et al, 2000) , but its putative role in multidrug resistance (MDR, reviewed by Moscow et al, 1997) is still under investigation. Closely related proteins such as MDR1 P-glycoprotein (P-gp, ABCB1, reviewed by Ambudkar et al, 1999) , breast cancer resistance protein (BCRP, ABCG2; Doyle et al, 1998) , and MRP1, -2, and -3 (ABCC1-3) are established MDR transporters. The exact range of substrates for MRP6 has not yet been determined, but a preliminary report suggested that MRP6 may be involved in the transport of certain anticancer agents, including anthracyclines and epipodophyllotoxins (M.G. Belinsky et al, Proceedings of the AACR, abstract 1510, 2001). Recently it was found that mutations in the MRP6 gene cause pseudoxanthoma elasticum (PXE), an inheritable disorder of the connective tissue involving impaired visual acuity, skin lesions, and cardiovascular complications (Bergen et al, 2000) . The expression of MRP6 in normal human tissues has only been studied at the mRNA level. High MRP6 mRNA levels were reported in liver and kidney, whereas low expression was found in a range of other tissues, including lung, intestines, retina, skin, and vessel walls (Bergen et al, 2000; Kool et al, 1999) .
Figure 1.
Detection of the approximately 65 kD MRP6-MBP fusion protein and full length MRP6 from protein preparations of MRP6-transfected HEK 293 cells, using anti-MRP6 Mab M 6 II-7. The approximately 180,000 kD MRP6 migrates slightly faster than MRP2, as shown by control lanes stained for MRP2, using M 2 III-6 and MRP2-transfected cells. Total cell lysates were made as previously described (Scheffer et al, 2000) . Ten to forty g of cell lysates or fusion proteins were fractionated on a 7% polyacrylamide slab gel and transferred onto a nitrocellulose membrane by electroblotting. After blocking, the membrane was incubated for 2 hours with primary antibody in the appropriate dilution. Horseradish peroxidase (HRP)-labeled-anti-rat or -mouse serum (1:1000; Dako, Copenhagen, Denmark) was used as a secondary antibody. Enhanced chemoluminescence (Amersham, Buckinghamshire, United Kingdom) was used to detect Mab binding.
Figure 2.
Immunohistochemical staining of normal human kidney, using HRP-labeled rabbit-anti-rat serum, fluorescein isothiocyanate (FITC)-labeled tyramine, HRP-labeled rabbit F(ab') 2 -anti-FITC and aminoethyl carbazole as the chromogen. M 6 II-31 shows the presence of MRP6 in the basolateral membranes of the proximal tubuli (a). Control stainings are with negative control antibody (b), anti-MRP2 mouse Mab M 2 III-6 (c), and anti-Tamm-Horsfall rabbit polyclonal antiserum (d). M 2 III-6 stains the apical membranes of the proximal tubules. The Tamm-Horsfall protein is localized in the early distal convoluted tubules and the thick ascending loops of Henle. 
-, no reactivity; ϩ/Ϫ, very weak reactivity; ϩ, weak reactivity; ϩϩ, moderate reactivity; ϩϩϩ, strong reactivity; nd, not determined. a (Scheffer et al, 2000) . (Scheffer et al, 2000) and unpublished.
Scheffer et al of these cell lines (Table 1 ). In line with normal tissue distribution studies at the mRNA level, considerable MRP6 staining in frozen sections of normal human tissues appeared to be restricted to kidney and liver. In the other tissues examined, including lung, brain, bladder, tonsil, spleen, heart, colon, adrenal gland, gall bladder, skeletal muscle, testis, ovary, placenta, parotis, esophagus, stomach, and pancreas, no MRP6 staining was observed. Surprisingly, also in sections of human skin and retina, no MRP6 staining could be observed, despite the fact that mutations in MRP6 were implicated in the connective tissue disorder PXE. Ongoing studies are investigating the direct or indirect role of (mutated) MRP6 in the eye and in skin lesions of PXE patients.
In kidney, MRP6 was located at the basolateral membranes of the proximal tubules (Fig. 2a) . The staining pattern paralleled the staining observed with the anti-MRP2 Mab M 2 III-6, but, as previously reported (Scheffer et al, 2000) , the latter Mab rather stained the apical membranes (Fig. 2c) . Control stainings with anti-Tamm-Horsfall polyclonal antiserum showed that this antigen does not co-localize with MRP6 (Fig. 2d) . The Tamm-Horsfall protein is localized in the early distal convoluted tubules and the thick ascending loops of Henle.
In liver, the anti-MRP6 Mabs strongly stained the membranes of the hepatocytes (Fig. 3a) . In contrast to data obtained with a polyclonal antiserum in rats (Madon et al, 2000) , the staining appeared to be located exclusively at the basolateral membranes, leaving, at closer look, especially the cross-sections of the canalicular membranes as particularly unstained regions in a marked pattern. A control staining for MRP2 (known to be present at the canalicular membranes [Scheffer et al, 2000] ) is shown in Figure 3c . To further investigate the presence or absence of MRP6 at the hepatocanalicular membranes, we performed a double staining for MRP6 and MRP2 using secondary reagents labeled with different fluorochromes. The proteins appeared to be present mutually exclusive at the basolateral and canalicular membranes, respec-
Figure 3.
Immunohistochemical staining of normal human liver, using HRP-labeled rabbit-anti-rat serum, FITC-labeled tyramine, HRP-labeled rabbit F(ab') 2 -anti-FITC and aminoethyl carbazole as the chromogen. M 6 II-31 shows the presence of MRP6 in the basolateral membranes of the hepatocytes (a). Control stainings are with negative control antibody (b) and anti-MRP2 Mab M 2 III-6 (c). M 2 III-6 stains the canalicular membranes of the hepatocytes. d, A fluorescent double staining for MRP6 and MRP2 is shown, using rat anti-MRP6 Mab M 6 II-31, HRP-labeled rabbit-anti-rat and tyramine-FITC (green), followed by staining with mouse anti-MRP2 Mab M 2 III-6, biotin-labeled rabbit-anti-mouse and Cy3-labeled streptavidin (red). Nuclei were counter stained with 4',6-diamidino-2-phenylindole (DAPI; blue). MRP6 and MRP2 are present mutually exclusive at the basolateral-and canalicular membranes, respectively; no mixed fluorochrome color is observed. tively, as shown by the absence of mixed fluorochrome color (Fig. 3d) .
Examination of the reactivity of the anti-MRP6 Mabs on formalin fixed, paraffin embedded sections of human liver, using the citrate method as antigen retrieval, showed that the M 6 II-7 and M 6 II-21 Mab were unreactive on this type of material, whereas the M 6 II-31 Mab was reactive, albeit less than observed in frozen sections.
In frozen sections of a small panel of human tumor samples from tissue of different histogenetic origins (including tumors of the intestine, stomach, testis, prostate, lung, pancreas, bladder, adrenal gland, cervix, neurologic tissue, mamma, ovary, kidney, and melanoma, n ϭ 34), no clear MRP6 levels could be detected, indicating that the contribution of MRP6 to MDR in tumors may be rather limited.
The MRP6 specific rat Mabs should become valuable tools in further studying the substrate specificity and possible contribution of MRP6 to MDR and they should facilitate in-depth studies into the nature of the disease in PXE patients.
